- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RadNet earnings slip, volume rises
Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008.
Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008. For the three months ended Sept. 30, 2009, RadNet reported revenue of $133.4 million versus $130.9 million in 3Q 2008 and a loss of $1.7 million compared with net income of $138,000. On a same-center basis, including only centers that were part of RadNet for both the third quarters of 2009 and 2008, MRI volume increased 5.4%, CT volume increased 4.0%, and PET/CT volume increased 4.3%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 3.2% over the same quarter in the prior year.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
